📗 Cite This Artifact
Portable Driving Simulator for PD Assessment (NCT03969927)
Portable Driving Simulator for Parkinson's Disease Assessment (NCT03969927)
Overview
Portable Driving Simulator for Parkinson's Disease Assessment (NCT03969927)
Overview
NCT03969927 is an observational study evaluating the validity and reliability of a portable driving simulator for assessing driving ability in individuals with neurological conditions including Parkinson's disease, stroke, and multiple sclerosis. The study compares a low-fidelity portable driving simulator (PDS) against a high-fidelity fixed-base simulator to determine whether portable devices can provide adequate assessment capabilities for clinical and research purposes.
This research addresses a critical need in neurorehabilitation: the ability to objectively assess driving fitness in patients with neurological conditions who may be at increased risk for driving-related accidents. [@akinwuntan2019] Traditional driving assessments require expensive simulator equipment or on-road testing, limiting accessibility. Portable simulators could enable more widespread screening and follow-up evaluation. [@akinwuntan2019]
Trial Details
| Attribute | Value |
|-----------|-------|
| NCT Number | NCT03969927 |
| Status | Recruiting (as of August 2024) |
| Study Type | Observational |
| Conditions | Parkinson's Disease, Stroke, Multiple Sclerosis |
| Interventions | Low-Fidelity Portable Driving Simulator vs. High-Fidelity Fixed-Base Simulator |
| Sponsor | University of Kansas Medical Center |
| Principal Investigator | Abiodun E. Akinwuntan, PhD |
| Start Date | August 28, 2019 |
| Estimated Completion | June 30, 2025 |
| Enrollment | Not specified |
Research Objectives
Primary Objectives
Secondary Objectives
Outcome Measures
Primary Outcomes
| Measure | Description |
|---------|-------------|
| User-Friendliness | Likert scale (1-5) assessing ease of use and participant satisfaction |
| Simulator Sickness | Simulator Sickness Questionnaire (SSQ) scoring range 0-228.14 |
| Driving Performance | Composite score including lane position, speed adherence, traffic light reaction, and reaction time |
Secondary Outcomes
- Comparison of individual driving metrics between simulator types
- Correlation analysis between portable and high-fidelity measurements
- Subgroup analysis by neurological condition
Study Design
Methodology
The study employs a cross-sectional, within-subjects design where each participant completes driving tasks on both the portable and high-fidelity simulators. This approach allows direct comparison of the two assessment methods within the same individual, controlling for between-subject variability.
Assessment Components
Eligibility Criteria
Inclusion Criteria
- Adults aged 25-75 years
- Diagnosis of Parkinson's disease, stroke, or multiple sclerosis
- Valid driver's license for at least 3 years
- MMSE score ≥24 (cognitive eligibility)
- Binocular visual acuity at least 20/60
Exclusion Criteria
- Severe motor impairment preventing simulator interaction
- Active medical conditions contraindicated for driving
- Prior participation in this study
- Inability to provide informed consent
Significance for Parkinson's Disease
Driving assessment is particularly relevant for Parkinson's disease patients due to several disease-specific factors:
Motor Impairment Impact
- Bradykinesia and rigidity can affect reaction time and vehicle control
- Tremor may interfere with steering wheel manipulation
- Postural instability can compromise emergency maneuver execution
Cognitive Factors
- Executive dysfunction affects decision-making and divided attention
- Visual processing deficits may impair hazard recognition
- Memory impairments can affect navigation and task sequencing
Medication Effects
- Dopaminergic medications may cause daytime sleepiness
- On-off fluctuations can create unpredictable driving capability
- Dyskinesias may interfere with safe vehicle operation
Research Implications
A validated portable driving simulator could:
- Enable remote monitoring of driving fitness in PD patients
- Provide objective data for clinical driving recommendations
- Facilitate tracking of disease progression impact on driving
- Support rehabilitation interventions targeting driving-specific skills
Simulator Technology Comparison
Portable Driving Simulator (PDS) Specifications
The low-fidelity portable driving simulator under evaluation includes:
| Component | Specification |
|-----------|---------------|
| Display | Laptop or tablet screen (12-15 inch) |
| Controls | Keyboard-based or basic joystick |
| Software | Custom driving scenario software |
| Setup Time | < 10 minutes |
| Portability | Fits in standard carrying case |
| Cost | < $5,000 |
High-Fidelity Fixed-Base Simulator
The comparison system includes:
| Component | Specification |
|-----------|---------------|
| Display | Multi-screen immersive display (180°+ field of view) |
| Controls | Force-feedback steering wheel, brake/acceleration pedals |
| Motion | Platform with 3-6 degrees of freedom motion |
| Software | Full physics engine with realistic vehicle dynamics |
| Setup Time | 30-60 minutes |
| Space | Dedicated room required |
| Cost | $100,000-500,000 |
Key Differences for Assessment
The fundamental differences between portable and high-fidelity systems affect their utility:
However, for basic assessment metrics like lane position, reaction time, and speed maintenance, portable systems may provide adequate validity.
Driving Assessment Metrics
Lane Position Maintenance
This metric evaluates the driver's ability to maintain proper lane positioning:
- Measure: Standard deviation of lateral lane position
- Units: Meters from lane center
- PD Relevance: Impaired by bradykinesia affecting steering corrections and visual-spatial deficits
Speed Adherence
Compliance with speed limits and appropriate speed selection:
- Measure: Deviation from posted speed limit, speed variability
- Units: km/h or mph
- PD Relevance: Affected by impaired judgment, bradykinesia in acceleration/deceleration
Traffic Light Reaction
Response time and accuracy when approaching traffic signals:
- Measure: Reaction time from light change to brake application
- Units: Seconds
- PD Relevance: Delayed by bradykinesia, impaired visual processing, cognitive slowing
Hazard Detection
Recognition and response to unexpected road hazards:
- Measure: Time to detection, avoidance maneuvers
- Units: Seconds, response accuracy
- PD Relevance: Compromised by reduced divided attention, executive dysfunction
Overall Reaction Time
Composite measure of cognitive and motor response:
- Measure: Complex reaction time tasks
- Units: Milliseconds
- PD Relevance: Significantly prolonged in PD due to combined cognitive-motor impairment
Clinical Implementation Pathway
Phase 1: Validation (Current Study)
- Compare PDS metrics against gold-standard high-fidelity simulator
- Establish correlation coefficients for each metric
- Determine measurement error and reliability
Phase 2: Population Norms
- Collect normative data from healthy controls across age groups
- Establish cut-off scores for driving fitness
- Account for learning effects with repeated testing
Phase 3: Clinical Integration
- Develop decision algorithm for driving recommendation
- Create screening protocols for clinicians
- Establish retesting intervals for disease progression monitoring
Phase 4: Remote Assessment
- Enable at-home monitoring with consumer-grade equipment
- Track longitudinal changes in driving fitness
- Alert clinicians to concerning trends
Regulatory and Safety Considerations
Driving Fitness Assessment in PD
In most jurisdictions, driving is regulated but not systematically monitored:
- Self-Reporting: Patients typically must report medical conditions
- Physician Reporting: Varies by jurisdiction (some have mandatory reporting)
- Practical Testing: Often only triggered by accidents or incidents
Portable simulators could provide objective monitoring between clinical visits.
Simulator Sickness Considerations
Simulator sickness is a significant concern that can affect both assessment validity and participant safety:
Symptoms:
- Nausea and vomiting
- Dizziness and disorientation
- Headache
- Visual discomfort
- Patients with autonomic dysfunction may be more susceptible
- Baseline dizziness from PD medications may compound effects
- Need for pre-screening for history of motion sickness
Future Directions
Technology Evolution
Portable driving assessment technology is advancing rapidly:
Clinical Research Applications
Validated portable simulators could enable:
- Multi-Site Trials: Standardized assessment across geographic locations
- Longitudinal Monitoring: Track driving changes over disease progression
- Intervention Studies: Measure effects of medications or rehabilitation
- Telehealth Integration: Remote assessment for patients with mobility limitations
Driving Assessment in Parkinson's Disease
The Clinical Need for Driving Assessment
Driving is a complex instrumental activity of daily living that significantly impacts independence, quality of life, and employment for individuals with Parkinson's disease. The progressive nature of PD eventually compromises the motor, cognitive, and visual abilities essential for safe vehicle operation. Approximately 25-50% of individuals with PD eventually cease driving, with driving cessation occurring on average 3-5 years after diagnosis, though significant variability exists based on disease severity, comorbidities, and individual circumstances.
The loss of driving privileges has profound consequences:
Functional Impact:
- Reduced independence in daily activities
- Increased reliance on family members or public transportation
- Limited access to healthcare appointments, social activities, and community engagement
- Potential loss of employment for younger patients
- Depression and anxiety related to loss of independence
- Reduced self-esteem and sense of self-efficacy
- Social isolation and withdrawal
- Family strain due to increased caregiving demands
- Annual cost of PD-related driving cessation estimated at $10,000-20,000 per patient
- Increased healthcare costs due to transportation barriers
- Lost productivity for patients and caregivers
Why Driving Ability Declines in PD
Multiple PD-related factors impair driving ability:
Motor Symptoms:
- Bradykinesia affects reaction time and physical responses
- Rigidity limits neck rotation and mirror checking
- Tremor interferes with steering wheel control
- Postural instability compromises emergency maneuvers
- Freezing of gait can occur while driving
- Executive dysfunction impairs decision-making and divided attention
- Visual-spatial deficits affect lane positioning and hazard detection
- Memory impairment may affect route navigation
- Attention deficits reduce ability to process multiple stimuli
- Psychomotor slowing extends reaction times
- Reduced contrast sensitivity affects low-light driving
- Color vision deficits may impair traffic signal recognition
- Diplopia (double vision) can occur with PD medications
- Visual field defects may reduce hazard awareness
- Daytime sleepiness from PD or medications
- Orthostatic hypotension causes dizziness
- Anxiety and panic can impair driving
- Dopaminergic medications can cause sudden "off" periods
- Dyskinesias may interfere with vehicle control
- Sleep attacks (sudden onset of sleep) are rare but dangerous
Current Assessment Methods
Currently available driving assessment methods include:
On-Road Testing:
- Gold standard but resource-intensive
- Requires certified examiner and appropriate vehicle
- Not available in all regions
- May not be covered by insurance
- Can be stressful for patients
- Excellent validity but cost-prohibitive
- Requires dedicated space and equipment
- Not portable or accessible
- Limited availability at specialized centers
- Useful screening tools but do not assess actual driving
- Examples: Trail Making Test, Useful Field of View
- Do not capture the integration of skills needed for driving
- Subjective and potentially unreliable
- May underreport or overreport difficulties
- Useful but not sufficient alone
The Promise of Portable Simulation
Portable driving simulators offer a middle ground:
Advantages:
- More valid than paper tests (includes actual driving behavior)
- More accessible than high-fidelity simulators
- Lower cost allows wider deployment
- Can be used in community settings
- Enables longitudinal monitoring
- Can be deployed in patient's home
- Lower fidelity than fixed simulators
- May not replicate all driving scenarios
- Learning effects with repeated testing
- Technical reliability concerns
The NCT03969927 Trial Design
Study Methodology
The trial employs a cross-sectional, within-subjects design:
Design Rationale:
- Each participant serves as their own control
- Eliminates between-subject variability
- Requires smaller sample size
- Allows direct comparison of simulator types
- Participants complete driving tasks on both simulators
- Order randomized to control for order effects
- Adequate washout between sessions
- Same scenarios presented on both systems
- Standardized lighting conditions
- Consistent instructions
- Trained research staff present
- Same cognitive screening conducted
Task Scenarios
Lane Keeping:
- Standard highway driving scenario
- Maintain position in lane
- No other traffic
- 3-5 minute duration
- Variable speed limit zones
- Maintain appropriate speed
- Smooth acceleration/deceleration
- 3-5 minute duration
- Intersections with signal changes
- Stop on red, proceed on green
- Yellow light decisions
- 5-10 scenarios
- Pedestrians entering road
- Vehicles merging
- Road debris
- Unexpected obstacles
- Multiple stimuli presented
- Varied response requirements
- Measures cognitive processing speed
Data Quality Assurance
Training:
- Research staff trained on both systems
- Standardized instructions
- Consistent prompts
- Real-time observation during testing
- Technical issues recorded
- Data integrity checks
- Clear explanation of tasks
- Practice trials before data collection
- Encouragement to do their best
Scientific Validation
Validation Metrics
The trial assesses multiple types of validity:
Concurrent Validity:
- Correlation between portable and high-fidelity metrics
- Expected: moderate to high correlation (r > 0.5)
- Different metrics may have different validity
- Do metrics measure the intended constructs?
- Comparison with established measures
- Known-groups validity (PD vs. controls)
- Do simulator metrics predict on-road performance?
- More difficult to assess (requires on-road testing)
- May be assessed in future studies
Expected Outcomes
Based on prior research, we expect:
High Correlation Metrics:
- Lane position standard deviation
- Speed maintenance
- Simple reaction time
- Complex scenario responses
- Hazard detection
- Real-world judgment
Reliability Assessment
Test-Retest Reliability:
- Important for longitudinal monitoring
- Expected: moderate to high reliability
- Learning effects may affect reliability
- Do metrics correlate within domains?
- Different aspects of driving may cluster
Clinical Translation
Implementing Portable Assessment
If the portable simulator proves valid, implementation pathways include:
Phase 1: Clinical Validation
- Establish cut-off scores for safety concerns
- Validate against on-road performance
- Develop interpretation guidelines
- Integrate into movement disorder clinics
- Train clinicians on interpretation
- Develop decision algorithms
- Enable at-home periodic assessment
- Track changes over disease progression
- Alert clinicians to concerning trends
Decision Algorithms
Clinicians need clear guidance:
Algorithm Components:
Considerations:
- Must balance safety with autonomy
- Consider patient and family preferences
- Account for regional regulations
- Document decision-making process
Ethical Considerations
Driving assessment raises important ethical issues:
Autonomy:
- Patients have right to make decisions
- But safety of self and others is paramount
- Need transparent discussion of risks
- Assessment results may affect insurance
- Must maintain appropriate confidentiality
- Understand mandatory reporting requirements
- Assessment should be accessible
- Not create barriers for underserved populations
- Consider costs and resources
Regulatory Framework
Reporting Requirements:
- Vary by jurisdiction
- Some areas require physician reporting
- Many areas rely on self-reporting
- Portable assessment may enhance monitoring
- Most jurisdictions require periodic renewal
- Medical conditions must be reported
- May require functional assessment
- Appeals process for license revocation
Future Directions
Technology Evolution
Driving assessment technology continues to evolve:
Virtual Reality (VR):
- More immersive experience with portable devices
- Better engagement and realism
- Costs decreasing rapidly
- Validation studies needed
- Most accessible option
- Uses phone sensors for basic assessment
- Limited but rapidly improving
- Good for screening, not full assessment
- Automated analysis of driving behavior
- Pattern recognition for safety concerns
- May identify subtle warning signs
- Requires validation
- Heart rate variability
- Eye tracking
- Brain-computer interfaces
- May detect fatigue or distraction
Research Priorities
Key questions for future investigation:
Integration with Clinical Care
Portable simulators could transform care:
Annual Screening:
- Part of routine PD management
- Track changes over time
- Trigger intervention when needed
- Baseline before medication changes
- Assess impact of new treatments
- Guide rehabilitation
- Track response to driving rehabilitation
- Identify areas for intervention
- Motivate patients with progress data
Technical Specifications
Portable Simulator Components
Hardware Requirements:
- Laptop or tablet computer (12-15 inch minimum)
- Keyboard with arrow keys or basic joystick
- Stable mounting surface
- Quiet environment
- Custom driving scenario software
- Data collection and storage
- Basic analytics
- Secure data transfer
- Weight: <5 kg (portable)
- Dimensions: fits in standard case
- Setup time: <10 minutes
- Power: standard electrical outlet
Validation Protocol Details
Testing Environment:
- Controlled lighting (not direct sunlight)
- Minimal external distractions
- Comfortable temperature
- Quiet environment
- Review instructions thoroughly
- Practice session (not scored)
- Comfortable seating position
- Correct screen distance/angle
- Continuous recording of metrics
- Session metadata (time, date, duration)
- Technical issues logged
- Backup data storage
Data Management
Privacy Considerations:
- HIPAA-compliant storage
- Limited access controls
- Secure transmission protocols
- Data retention policies
- Automatic range checks on data
- Manual review of outliers
- Inter-rater reliability for subjective metrics
- Regular equipment calibration
Comparative Analysis
Portable vs. Fixed Simulators
| Feature | Portable | Fixed (High-Fidelity) |
|---------|----------|----------------------|
| Initial Cost | <$5,000 | $100,000-500,000 |
| Space Required | Small | Dedicated room |
| Setup Time | <10 min | 30-60 min |
| Portability | High | None |
| Visual Fidelity | 2D display | 180°+ immersive |
| Control Fidelity | Basic keyboard/joystick | Force-feedback wheel |
| Motion Cues | None | 3-6 DOF motion |
| Validity for Basic Metrics | Moderate-high | High |
| Validity for Complex Scenarios | Lower | Higher |
Simulator vs. On-Road Testing
| Feature | Simulator | On-Road |
|---------|-----------|---------|
| Standardization | High | Variable |
| Safety | Very high | Some risk |
| Cost per Assessment | Low | High |
| Availability | Widespread | Limited |
| Validity | Good for basic | Excellent |
| Real-World Transfer | Moderate | Excellent |
| Legal Admissibility | Limited | Strong |
Driving Assessment in Other Conditions
The validation approach used in this trial may be applicable to other neurological conditions:
Stroke:
- Similar assessment needs
- Different specific impairments
- May benefit from portable monitoring
- Variable disease course
- Fatigue affects driving
- Portable assessment could help
- Cognitive impairment is key
- Assessment important for return to driving
- Portable tools may assist
- Vascular dementia, Lewy body dementia
- Driving safety concerns
- May benefit from monitoring
Implementation Challenges
Technical Limitations
Fidelity Constraints:
- Cannot replicate all real-world scenarios
- Limited visual detail
- Missing motion cues
- May not trigger all driving behaviors
- Performance improves with practice
- Need adequate washout between sessions
- Repeated testing requires adjustment
- Equipment reliability
- Software bugs
- Data quality
- Maintenance requirements
Patient Factors
Computer Literacy:
- Some patients unfamiliar with technology
- May affect performance independent of driving ability
- Training may be needed
- Cannot use standard controls
- Visual limitations
- Tremor affecting input devices
- May not take assessment seriously
- Practice effects if motivated
- Fatigue affecting performance
Clinical Integration
Workflow:
- Training staff on use
- Time in clinic schedule
- Data interpretation
- Reporting to patients
- Coverage for assessment
- Billing codes unclear
- May require advocacy
- Documentation standards
- Liability for adverse events
- Reporting requirements
Related Pages
- [Parkinson's Disease](/diseases/parkinsons-disease) — Main disease page](/proteins/parkin)
- [Driving and Parkinson's Disease](/therapies/rehabilitation/parkinsons-driving) — Related therapies](/proteins/parkin)
- [Clinical Trials Dashboard](/clinical-trials/dashboard) — All PD clinical trials](/clinical-trials)
- [Movement Disorders](/diseases/movement-disorders) — Related conditions
References
See Also
Related Analyses:
- [Is disrupted sleep a cause or consequence of neurodegeneration? Analyze the bidi](/analysis/SDA-2026-04-02-gap-20260402-003115)
- [Mitochondrial transfer between astrocytes and neurons](/analysis/SDA-2026-04-01-gap-v2-89432b95)
- [Immune atlas neuroinflammation analysis in neurodegeneration](/analysis/SDA-2026-04-02-gap-immune-atlas-neuroinflam-20260402)
- [Cytochrome Therapeutics](/experiment/exp-wiki-experiments-lipid-droplet-lysosome-axis-parkinsons)
- [Multiscale Computational Modeling of Protein Aggregation Kinetics](/experiment/exp-wiki-experiments-multiscale-protein-aggregation-modeling)
- [cGAS-STING Pathway Validation Study in Parkinson's Disease](/experiment/exp-wiki-experiments-cgas-sting-parkinsons)
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | clinical-trials-portable-driving-simulator-pd-nct03969927 |
| kg_node_id | None |
| entity_type | clinical |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-7710cfe55f61 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'clinical-trials-portable-driving-simulator-pd-nct03969927'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-clinical-trials-portable-driving-simulator-pd-nct03969927?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[Portable Driving Simulator for PD Assessment (NCT03969927)](http://scidex.ai/artifact/wiki-clinical-trials-portable-driving-simulator-pd-nct03969927)
http://scidex.ai/artifact/wiki-clinical-trials-portable-driving-simulator-pd-nct03969927